Safety Alert: NAFDAC Recalls Deekins Amoxycillin Capsule Batch Over Quality Issues
The National Agency for Food and Drug Administration and Control (NAFDAC) has announced the recall of a specific batch of Deekins Amoxycillin 500mg Capsules due to reports of serious adverse drug reactions.
In a statement shared on X (formerly Twitter) on Wednesday, NAFDAC identified the affected batch as Lot No. 4C639001, manufactured by Eco-med Pharma Ltd and marketed by DevineKings Pharmaceutical Ltd.
The recall was prompted by reports from a hospital detailing three cases of severe reactions in patients who were administered capsules from this batch.
The statement read:
“NAFDAC is notifying the public of the recall of one batch of Deekins Amoxycillin 500mg Capsules, with Lot No. 4C639001, manufactured by Eco-med Pharma Ltd and marketed by DevineKings Pharmaceutical Ltd.
“This action follows reports of serious adverse drug reactions associated with this batch. Eco-med Pharma Ltd reported that a hospital documented three cases of severe reactions linked to its use.”
Amoxicillin, a penicillin antibiotic, is commonly used to treat bacterial infections, including tonsillitis, bronchitis, sinusitis, pneumonia, and bacterial infections affecting the ear, nose, throat, skin, or urinary tract.
NAFDAC has advised healthcare professionals and consumers to immediately discontinue use of the affected batch and report any suspected cases of substandard or falsified medicines.
Reports can be made to the nearest NAFDAC office, by calling 0800-162-3322, or via email at sf.alert@nafdac.gov.ng.
Comments